Comparison of hemagglutination inhibition assay, an ELISA-based micro-neutralization assay and colorimetric microneutralization assay to detect antibody responses to vaccination against influenza A H1N1 2009 virus

Journal of Virological Methods

Volumn 171, Issue 2, 2011, Pages 369-373

  Grund, S ^a   Adams, O ^a   Wahlisch S ^b   Schweiger, B ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Antibody responses; Hemagglutination inhibition assay; Influenza (H1N1) 2009 virus; Neutralization assay; Vaccination

Indexed keywords

ANTISERUM; INFLUENZA VACCINE; VIRUS ANTIBODY;

2009 H1N1 INFLUENZA; ACCURACY; ADULT; ANIMAL CELL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; COLORIMETRIC MICRONEUTRALIZATION ASSAY; COLORIMETRY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY BASED MICRO NEUTRALIZATION TEST; HEMAGGLUTINATION INHIBITION TEST; HUMAN; HUMAN EXPERIMENT; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INTERMETHOD COMPARISON; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; REPRODUCIBILITY; SEROCONVERSION; VIRUS NEUTRALIZATION;

ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; NEUTRALIZATION TESTS; VIROLOGY;

ORTHOMYXOVIRIDAE;

EID: 78651233639     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2010.11.024     Document Type: Article

References (15)

1. Benne C.A., Harmsen M., De Jong J.C., Kraaijeveld C.A. Neutralization enzyme immunoassay for influenza virus. J. Clin. Microbiol. 1994, 32:987-990.
2. Frank A.L., Puck J., Hughes B.J., Cate T.R. Microneutralization test for influenza A and B and parainfluenza 1 and 2 viruses that uses continuous cell lines and fresh serum enhancement. J. Clin. Microbiol. 1980, 12:426-432.
3. Gitelman A.K., Kaverin N.V., Kharitonenkov I.G., Rudneva I.A., Sklyanskaya E.L., Zhdanov V.M. Dissociation of the haemagglutination inhibition and the infectivity neutralization in the reactions of influenza A/USSR/90/77 (H1N1) virus variants with monoclonal antibodies. J. Gen. Virol. 1986, 67(Pt. 10):2247-2251.
4. Hancock K., Veguilla V., Lu X., Zhong W., Butler E.N., Sun H., Liu F., Dong L., DeVos J.R., Gargiullo P.M., Brammer T.L., Cox N.J., Tumpey T.M., Katz J.M. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N. Engl. J. Med. 2009, 361:1945-1952.
5. Ikonen N., Strengell M., Kinnunen L., Osterlund P., Pirhonen J., Broman M., Davidkin I., Ziegler T., Julkunen I. High frequency of cross-reacting antibodies against 2009 pandemic influenza A (H1N1) virus among the elderly in Finland. Euro Surveill. 2010, 15.
6. Lehtoranta L., Villberg A., Santanen R., Ziegler T. A novel, colorimetric neutralization assay for measuring antibodies to influenza viruses. J. Virol. Methods 2009, 159:271-276.
7. Lenette H.L., Schmidt N.J. Influenza viruses. Diagnostic Procedures for Viral Rickettsial and Chlamydial Infections 1979, pp. 585-609.
8. Liang X.F., Wang H.Q., Wang J.Z., Fang H.H., Wu J., Zhu F.C., Li R.C., Xia S.L., Zhao Y.L., Li F.J., Yan S.H., Yin W.D., An K., Feng D.J., Cui X.L., Qi F.C., Ju C.J., Zhang Y.H., Guo Z.J., Chen P.Y., Chen Z., Yan K.M., Wang Y. Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 2010, 375:56-66.
9. Pascua P.N., Song M.S., Lee J.H., Park K.J., Kwon H.I., Baek Y.H., Hong S.P., Rho J.B., Kim C.J., Poo H., Ryoo T.S., Sung M.H., Choi Y.K. Evaluation of the efficacy and cross-protectivity of recent human and swine vaccines against the pandemic (H1N1) 2009 virus infection. PLoS One 2009, 4:e8431.
10. Plennevaux E., Sheldon E., Blatter M., Reeves-Hoche M.K., Denis M. Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials. Lancet 2010, 375:41-48.
11. Remarque E.J., de Bruijn I.A., Boersma W.J., Masurel N., Ligthart G.J. Altered antibody response to influenza H1N1 vaccine in healthy elderly people as determined by HI ELISA, and neutralization assay. J. Med. Virol. 1998, 55:82-87.
12. Roman F., Vaman T., Gerlach B., Markendorf A., Gillard P., Devaster J.M. Immunogenicity and safety in adults of one dose of influenza A H1N1 v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observer-blind, randomised trial. Vaccine 2010, 28:1740-1745.
13. Rowe T., Abernathy R.A., Hu-Primmer J., Thompson W.W., Lu X., Lim W., Fukuda K., Cox N.J., Katz J.M. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J. Clin. Microbiol. 1999, 37:937-943.
14. van de Water C., van Dura E.A., van der Stap J.G., Brands R., Boersma W.J. Rapid in vitro micro-cytotoxicity tests for the detection and quantitation of neutralizing antibodies to both viruses and toxins. J. Immunol. Methods 1993, 166:157-164.
15. Zhu F.C., Wang H., Fang H.H., Yang J.G., Lin X.J., Liang X.F., Zhang X.F., Pan H.X., Meng F.Y., Hu Y.M., Liu W.D., Li C.G., Li W., Zhang X., Hu J.M., Peng W.B., Yang B.P., Xi P., Wang H.Q., Zheng J.S. A novel influenza A (H1N1) vaccine in various age groups. N. Engl. J. Med. 2009, 361:2414-2423.